Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations

Lancet Microbe. 2022 May;3(5):e325-e326. doi: 10.1016/S2666-5247(22)00061-1. Epub 2022 Mar 15.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Immunocompromised Host
  • SARS-CoV-2* / genetics

Substances

  • Antibodies, Viral